Copyright
©The Author(s) 2015.
World J Nephrol. Feb 6, 2015; 4(1): 57-73
Published online Feb 6, 2015. doi: 10.5527/wjn.v4.i1.57
Published online Feb 6, 2015. doi: 10.5527/wjn.v4.i1.57
Table 1 Performance comparison of creatinine-based estimated glomerular filtration rate in North America/Europe/Australia
Ref. | Country | Patients, n | mGFR | eGFR | Results | ||
(value mL/min×1.73 m2, SD) | (equation) | 1Bias (95%CI) mL/min×1.73 m2 | 2Precision (95%CI) | 3P30 (95%CI), % | |||
Murata et al[180] | United States | 5238 | I-Iothalamate, urine (55.9, SD 29.7) | MDRD CKD-EPI | -4.1 -0.7 | ND | 77.6 78.4 |
Levey et al[62] | United States | 3896 | I-Iothalamate, urine and others (68, SD 36) | MDRD CKD-EPI | -5.5 (-5.0 to -5.9) -2.5 (-2.1 to -2.9) | 0.274 (0.265-0.283)4 0.250 (0.241-0.259)4 | 80.6 (79.5-82.0) 84.1 (83.0-85.3) |
Lane et al[181] | United States | 425 | I-Iothalamate, urine (50, IQR 29 to 69) | MDRD CKD-EPI | -1.0 -1.7 | 15.05 13.85 | 75 80 |
Michels et al[77] | The Netherlands | 271 | I-Iothalamate, urine (78.2, SD 33) | MDRD CKD-EPI | 14.6 mL/min 12.3 mL/min | 19.96 12.16 | 81.2 84.5 |
Tent et al[182] | The Netherlands | 253 before donation, 253 after donation | I-Iothalamate, urine (115, SD 20) and (73, SD 13) | MDRD CKD-EPI MDRD CKD-EPI | -22 mL/min (20-25) -14 mL/min (11-16) -15 mL/min (14-16) -11 mL/min (9-11) | 20 (14-26)5 18 (14-22)5 12 (9-15)5 12 (10-16)5 | 73 (68-79) 89 (85-93) 71 (65-76) 89 (85-93) |
Kukla et al[183] | United States | 107 on steroid-free early post tranplantation 81 on steroid-free at 1 yr | I-Iothalamate, urine (55.5, SD 17) and (56.8, SD 17.7) | MDRD CKD-EPI MDRD CKD-EPI | 8.23 13.30 2.40 6.91 | 17.94 21.14 15.84 17.34 | 71.7 58.5 75.0 66.7 |
White et al[184] | Canada | 207 | Tc-DTPA, plasma (58, SD 22) | MDRD CKD-EPI | -7.4 -5.2 | 14.45 15.75 | 79 (73-84) 84 (78- 88) |
Pöge et al[185] | Germany | 170 | Tc-DTPA, plasma (39.6, IQR 11.8 to 82.9) | MDRD CKD-EPI | 4.49 8.07 | 10.06 10.96 | 71.8 64.1 |
Jones[186] | Australia | 169 | Tc-DTPA, plasma (75, IQR 5 to 150) | MDRD CKD-EPI | -37 -1.57 | ND | 81 86 |
Cirillo et al[187] | Italy | 356 | Inulina, plasma (71.5, SD 36.3) | MDRD CKD-EPI | -5.2 -0.9 | 14.96 13.26 | 87.4 88.2 |
Eriksen et al[188] | Norway | 1621 | Iohexol, plasma (91.7, SD 14.4) | MDRD CKD-EPI | 1.3 (0.4-2.1) 2.9 (2.2-3.5) | 18.2 (17.2-19.5)5 15.4 (14.5-16.3)5 | 93 (91-94) 95 (94-96) |
Redal-Baigorri et al[189] | Denmark | 185 | Cr-EDTA, plasma (85.1, SD 20.3) | MDRD CKD-EPI | 0.81 (IQR, -1.56 to 3.19) 1.16 (IQR, -0.76 to 3.09) | 16.496 13.376 | 88.6 89.7 |
- Citation: Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol 2015; 4(1): 57-73
- URL: https://www.wjgnet.com/2220-6124/full/v4/i1/57.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i1.57